Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(2)

Detailed Status

unknown2

Recruiting1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%

unknown250%

completed125%

Recent Activity

1 active trials

Showing 4 of 4

recruiting

Auditory Functions in Patients With Multiple Sclerosis

NCT06164483

completednot_applicable

IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis

NCT04697407

unknown

SouthEast Asia Encephalitis Project

NCT04089436

unknown

Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

NCT03486665

Clinical Trials (4)

Showing 4 of 4 trials

NCT06164483

Auditory Functions in Patients With Multiple Sclerosis

Recruiting

NCT04697407Not Applicable

IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis

Completed

NCT04089436

SouthEast Asia Encephalitis Project

Unknown

NCT03486665

Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

Unknown

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4